Literature DB >> 16790789

A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1.

Johanna Rivera1, Antonio Nakouzi, Nareen Abboud, Ekaterina Revskaya, David Goldman, R John Collier, Ekaterina Dadachova, Arturo Casadevall.   

Abstract

Antibody (Ab) responses to Bacillus anthracis toxins are protective, but relatively few protective monoclonal antibodies (MAbs) have been reported. Protective antigen (PA) is essential for the action of B. anthracis lethal toxin (LeTx) and edema toxin. In this study, we generated two MAbs to PA, MAbs 7.5G and 10F4. These MAbs did not compete for binding to PA, consistent with specificities for different epitopes. The MAbs were tested for their ability to protect a monolayer of cultured macrophages against toxin-mediated cytotoxicity. MAb 7.5G, the most-neutralizing MAb, bound to domain 1 of PA and reduced LeTx toxicity in BALB/c mice. Remarkably, MAb 7.5G provided protection without blocking the binding of PA or lethal factor or the formation of the PA heptamer complex. However, MAb 7.5G slowed the proteolytic digestion of PA by furin in vitro, suggesting a potential mechanism for Ab-mediated protection. These observations indicate that some Abs to domain 1 can contribute to host protection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790789      PMCID: PMC1489699          DOI: 10.1128/IAI.00150-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.

Authors:  Shihui Liu; Stephen H Leppla
Journal:  J Biol Chem       Date:  2002-12-04       Impact factor: 5.157

2.  Adult B-cell repertoire is biased toward two heavy-chain variable-region genes that rearrange frequently in fetal pre-B cells.

Authors:  A M Lawler; P S Lin; P J Gearhart
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin.

Authors:  S F Little; S H Leppla; E Cora
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The nucleotide sequence of a 5.5-kilobase DNA segment containing the mouse kappa immunoglobulin J and C region genes.

Authors:  E E Max; J V Maizel; P Leder
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

6.  Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes.

Authors:  H Sakano; R Maki; Y Kurosawa; W Roeder; S Tonegawa
Journal:  Nature       Date:  1980-08-14       Impact factor: 49.962

Review 7.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.

Authors:  Fabien Brossier; Martine Lévy; Annie Landier; Pierre Lafaye; Michèle Mock
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

9.  Crystal structure of a complex between anthrax toxin and its host cell receptor.

Authors:  Eugenio Santelli; Laurie A Bankston; Stephen H Leppla; Robert C Liddington
Journal:  Nature       Date:  2004-07-04       Impact factor: 49.962

Review 10.  Anthrax toxin.

Authors:  R John Collier; John A T Young
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

View more
  32 in total

1.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.

Authors:  Lisa Winterroth; Johanna Rivera; Antonio S Nakouzi; Ekaterina Dadachova; Arturo Casadevall
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

3.  Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.

Authors:  Eric K Dumas; Melissa L Nguyen; Philip M Cox; Heidi Rodgers; Joanne L Peterson; Judith A James; A Darise Farris
Journal:  Vaccine       Date:  2013-02-13       Impact factor: 3.641

4.  Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.

Authors:  Yong Sung Park; Jin Hyup Lee; Chien-Fu Hung; T-C Wu; Tae Woo Kim
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

5.  Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.

Authors:  Nareen Abboud; Magdia De Jesus; Antonio Nakouzi; Radames J B Cordero; Mario Pujato; András Fiser; Johanna Rivera; Arturo Casadevall
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

6.  Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax.

Authors:  Johanna Rivera; Antonio S Nakouzi; Alfred Morgenstern; Frank Bruchertseifer; Ekaterina Dadachova; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

7.  Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.

Authors:  Cassandra D Kelly-Cirino; Nicholas J Mantis
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

8.  Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies.

Authors:  Siu-Kei Chow; Cameron Smith; Thomas MacCarthy; Mary Ann Pohl; Aviv Bergman; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

9.  Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro.

Authors:  David L Goldman; WangYong Zeng; Johanna Rivera; Antonio Nakouzzi; Arturo Casadevall
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

10.  Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection.

Authors:  Ronit Rosenfeld; Hadar Marcus; Einat Ben-Arie; Bat-El Lachmi; Adva Mechaly; Shaul Reuveny; Orit Gat; Ohad Mazor; Arie Ordentlich
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.